Cargando…

The Brain-gut Axis-where are we now and how can we Modulate these Connections?

A traumatic brain injury (TBI) initiates an inflammatory response with molecular cascades triggered by the presence of necrotic debris, including damaged myelin, hemorrhages and injured neuronal cells. Molecular cascades prominent in TBI-induced inflammation include the release of an excess of proin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabrowski, Wojciech, Siwicka-Gieroba, Dorota, Kotfis, Katarzyna, Zaid, Sami, Terpilowska, Sylwia, Robba, Chiara, Siwicki, Andrzej K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719292/ https://www.ncbi.nlm.nih.gov/pubmed/33213347 http://dx.doi.org/10.2174/1570159X18666201119155535

Ejemplares similares

Cytotoxicity of Iron (III), Molybdenum (III), and their Mixtures in BALB/3T3 and HepG2 Cells
por: Terpiłowska, Sylwia, et al.
Publicado: (2018)

Cell Viability in Normal Fibroblasts and Liver Cancer Cells After Treatment with Iron (III), Nickel (II), and their Mixture
por: Terpiłowska, Sylwia, et al.
Publicado: (2018)

The Connection Between Selected Caspases Levels in Bronchoalveolar Lavage Fluid and Severity After Brain Injury
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2022)

Decompressive Craniectomy Improves QTc Interval in Traumatic Brain Injury Patients
por: Dabrowski, Wojciech, et al.
Publicado: (2020)

Suppression of Electrographic Seizures Is Associated with Amelioration of QTc Interval Prolongation in Patients with Traumatic Brain Injury
por: Dabrowski, Wojciech, et al.
Publicado: (2021)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Pathomechanisms of Non-Traumatic Acute Brain Injury in Critically Ill Patients
por: Dabrowski, Wojciech, et al.
Publicado: (2020)

Radiologic approach to axial spondyloarthritis: where are we now and where are we heading?
por: Kucybała, Iwona, et al.
Publicado: (2018)

Cerebral Oxygen Delivery and Consumption in Brain-Injured Patients
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2022)

Potentially Detrimental Effects of Hyperosmolality in Patients Treated for Traumatic Brain Injury
por: Dabrowski, Wojciech, et al.
Publicado: (2021)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Credibility of the Neutrophil-to-Lymphocyte Count Ratio in Severe Traumatic Brain Injury
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2021)

The Neutrophil/Lymphocyte Count Ratio Predicts Mortality in Severe Traumatic Brain Injury Patients
por: Siwicka-Gieroba, Dorota, et al.
Publicado: (2019)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Usefulness of Cerebral Oximetry in TBI by NIRS
por: Barud, Małgorzata, et al.
Publicado: (2021)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Articular Cartilage Repair: Where We Have Been, Where We Are Now, and Where We Are Headed
por: Grande, Daniel A., et al.
Publicado: (2013)

The prone position must accommodate changes in IAP in traumatic brain injury patients
por: Dabrowski, Wojciech, et al.
Publicado: (2021)

Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients
por: Dabrowski, Wojciech, et al.
Publicado: (2020)

Yellow fever control in Cameroon: Where are we now and where are we going?
por: Wiysonge, Charles Shey, et al.
Publicado: (2008)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Structure functions and the EMC effect: where are we now and where are we going to?
por: Wimpenny, S J
Publicado: (1984)

Cardiovascular Tissue Engineering: Where We Come From and Where Are We Now?
por: Smit, Francis E., et al.
Publicado: (2015)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Where are we now and where are we heading in muscle invasive bladder cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2020)

Simulation training in hand surgery — where are we now and where should we be?
por: Harsten, Rebecca, et al.
Publicado: (2021)

Future Perspectives in Pediatric Dentistry: Where are We Now and where are We Heading?
por: Rodrigues, Jonas A, et al.
Publicado: (2022)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_vr6ct2fe30jo9f23qqeoq7f3hf